Nanotechnology Now - Press Release: ICTV Comments on the Derma Wand's Gorgeous Results

Home > Press > ICTV Comments on the Derma Wand's Gorgeous Results

Abstract:
International Commercial Television, Inc. (OTCBB:ICTL) ("ICTV" or "The Company") a premier consumers products company employing the strength of revenue generating, prominently profiled infomercial campaigns to market and brand unique "Fountain of Youth" products to the global consumer through multi-channels of distribution including Direct Response Television ("DRTV"), retail and the internet comments on its rapid and continuing business expansion.

ICTV Comments on the Derma Wand's Gorgeous Results

BAINBRIDGE ISLAND, WA | Posted on August 22nd, 2007

The Company is pleased to report that the financial performance of the Company in the second quarter of 2007 surpassed the total revenue and net profit earned by the Company in all of 2006. Gross Revenue for 2nd Quarter 2007 was $3,151,752 versus the year end 2006 total of $2,977,074.00. 2nd Quarter 2007 net profit was $468,656.00 with a 0.04 EPS compared to 2006 year end profit of $343,536.00 with a 0.03 EPS.

Other Comparative figures are as follows.

- Revenue for the 2nd Quarter 2007 of $3,151,752.00 increased 87% from 2007 1st Quarter of $1,683,045.

- Net Profit for 2nd Quarter 2007 of $468,656.00 increased 126% from 2007 1st Quarter of $206,989.00

- 2nd Quarter 2007 Gross Revenue vs. 2nd Quarter 2006 Gross Revenue increased by 1646%

- Profit growth 2nd Quarter 2007 vs. 2nd Quarter 06 was 312%




                       6 Month Comparative Figures


                            June 30, 2007            June 30, 2006
                            -------------            -------------


NET SALES                      $4,834,797                 $502,573


COST OF SALES                  $1,296,588                 $273,944
                            -------------            -------------



GROSS PROFIT                    3,538,209                  228,629
                            -------------            -------------


OPERATING
EXPENSES                        2,865,774                  466,100
                            -------------            -------------



OPERATING INCOME (LOSS)           672,435                 (237,471)


NET INCOME (LOSS)                $675,645                $(239,283)
                            -------------            -------------
                            -------------            -------------



NET INCOME PER SHARE                $0.06                   $(0.02)
                            -------------            -------------
                            -------------            -------------

The rapid revenue growth targets the Company has achieved is based on the Derma Wand, the Company's first "Fountain of Youth" product, and its velocity of sales increasing in its primary distribution channel of direct response television ("DRTV"). The Company is now commencing rapid expansion of its multi-distribution strategy for the Derma Wand. Along with the recent addition of the Cell-RX skincare line and other unique health and beauty products now being accepted by the Company's international customer base, ICTV is now positioned for accelerated revenue and profit growth.

Mr. Claney CEO of ICTV stated "This record 2nd Quarter is a result of an initial strong demand for our innovative product driven by a profitable DRTV campaign." Mr. Claney continues "I truly believe ICTV will make rapid and substantial progress by selling an effective Health and Beauty product blend along with the branding power of profitable DRTV campaigns which will power all forms of traditional product distribution."

####

About International Commercial Television, Inc.
Headquartered in Bainbridge Island Washington, International Commercial Television, Inc. is a rapidly expanding global consumer products company marketing unique and effective "Fountain of Youth" products with distribution channels in place in over 35 countries worldwide. The Company utilizes a distinctive marketing strategy and multi-channel distribution model to develop, market and sell health and beauty products under its Derma Wand and DermaVital Skincare brands. Marketing and distribution of the Company's products through infomercials, live home shopping television, mass retailers, spas and salons, online shopping and various other forms of distribution.

About the Derma Wand

The Company-owned Derma Wand is a highly effective, patented and unique in-home skin care appliance that helps reduce the appearance of fine lines and wrinkles, and assists in cosmetically improving overall skin appearance.

About Cell RX

The Company has acquired the worldwide rights through a license agreement to "Cell RX" skincare system from Smart Skincare Inc. The key ingredient of Cell RX is Nano-C Powder which uses a patented nanotechnology to preserve the potency of nature's most powerful anti-oxidant and collagen builder - Vitamin C. Nano-C starts as a powder but when applied to the skin's surface it becomes a cream which is instantly absorbed right into the skin and thereby most effectively employing the dynamic skin rejuvenating properties of Nano-C powder.

About the DermaVitál Skincare Line

ICTV's DermaVitál Skin Care range has been specially formulated to enhance the effectiveness of the results achieved by using the Derma Wand. The lead product in the range is the DermaVitál Hydra-Infusion Treatment and Hydrating Skin Mist, a formula that received a U.S. patent for effectively allowing water to be absorbed into skin.

Forward-Looking Statements

The matters discussed in this press release may contain "Forward-Looking statements" (as such term is defined in the Private Securities Litigation Reform Act of 1995). The Company relies on the safe harbor provisions of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, apply to Forward-looking statements made by ICTV. You should not place undue reliance on Forward-looking statements. These Forward-looking statements involve risks and uncertainties. The actual results that ICTV achieves may differ materially from any forward-looking statements due to such risks and uncertainties.

For more information, please click here

Contacts:
ICTV's Investor Relations Department
1-888-449-ICTV (4288)

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: